Table 3. Treatment and Survival Outcomes of 78,481 patients with Endometrioid Adenocarcinoma and 3,706 patients with Carcinosarcoma of the Uterus from the Surveillance Epidemiology and End Result (SEER) Database (1973-2010).

Abbreviations: N = number; SD = standard deviation; Diff = Differentiated.*p value: statistical significance, < 0.05; ^age-adjusted incidence for the years 1973-2010

Variables	Overall	Carcinosarcoma		Endometrioid Adenocarcinoma		p-values
Treatment N(%)
No treatment	3,185 (3.9)	260 (7.0)*		2,925 (3.7)		<0.001
Surgery only	58,205 (70.8)	2,030 (54.8)		56,175 (71.6)*		<0.001
Radiation only	978 (1.2)	138 (3.7)		840 (1.1)		<0.001
Both surgery and radiation	19,506 (23.7)	1,256 (33.9)*		18,250 (23.3)		<0.001
Unknown	313 (0.4)	22 (0.6)		291 (0.4)		0.03
Mean Survival (years)	16.88±0.3	6.63±0.24		17.69±0.68		0.025
Survival by treatment (years±SD)
No treatment		0.74±0.11		7.21±0.24		<0.001
Surgery only		5.83±0.31		20.38±1.16*		<0.001
Radiation only		2.80±0.68		3.50±0.24		<0.001
Both surgery and radiation		9.38±0.45*		15.24±0.46		<0.001
Overall Survival (Cumulative %)
1-year 2-year 5-year			47*		95	<0.001
			38*		88	<0.001
			14*		62	<0.001